Synergy Pharmaceuticals (FRA:S90) COGS-to-Revenue : 0.35 (As of Sep. 2018)

View and export this data going back to 2012. Start your Free Trial

What is Synergy Pharmaceuticals COGS-to-Revenue?

Synergy Pharmaceuticals's Cost of Goods Sold for the three months ended in Sep. 2018 was €3.36 Mil. Its Revenue for the three months ended in Sep. 2018 was €9.52 Mil.

Synergy Pharmaceuticals's COGS to Revenue for the three months ended in Sep. 2018 was 0.35.

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin. Synergy Pharmaceuticals's Gross Margin % for the three months ended in Sep. 2018 was 64.68%.

Synergy Pharmaceuticals COGS-to-Revenue Historical Data

The historical data trend for Synergy Pharmaceuticals's COGS-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Synergy Pharmaceuticals COGS-to-Revenue Chart

Synergy Pharmaceuticals Annual Data

Trend

Dec08

Dec09

Dec10

Dec11

Dec12

Dec13

Dec14

Dec15

Dec16

Dec17

COGS-to-Revenue

Get a 7-Day Free Trial

0.52

Synergy Pharmaceuticals Quarterly Data
	Dec13	Mar14	Jun14	Sep14	Dec14	Mar15	Jun15	Sep15	Dec15	Mar16	Jun16	Sep16	Dec16	Mar17	Jun17	Sep17	Dec17	Mar18	Jun18	Sep18
COGS-to-Revenue	Get a 7-Day Free Trial															0.34	0.41	0.43	0.32	0.35

Synergy Pharmaceuticals COGS-to-Revenue Calculation

Synergy Pharmaceuticals's COGS to Revenue for the fiscal year that ended in Dec. 2017 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=	7.445	/	14.213
	=	0.52

Synergy Pharmaceuticals's COGS to Revenue for the quarter that ended in Sep. 2018 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=	3.361	/	9.517
	=	0.35

Synergy Pharmaceuticals (FRA:S90) COGS-to-Revenue Explanation

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin.

Synergy Pharmaceuticals's Gross Margin % for the three months ended in Sep. 2018 is calculated as:

Gross Margin %	=	1	-	COGS to Revenue
	=	1	-	Cost of Goods Sold / Revenue
	=	1	-	3.361 / 9.517
	=	64.68 %

A company that has a moat can usually maintain or even expand their Gross Margin. A company can increase its Gross Margin in two ways. It can increase the prices of the goods it sells and keeps its Cost of Goods Sold unchanged. Or it can keep the sales price unchanged and squeeze its suppliers to reduce the Cost of Goods Sold. Warren Buffett believes businesses with the power to raise prices have moats.

Synergy Pharmaceuticals COGS-to-Revenue Related Terms

Thank you for viewing the detailed overview of Synergy Pharmaceuticals's COGS-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Synergy Pharmaceuticals (FRA:S90) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Synergy Pharmaceuticals Inc (FRA:S90) » Definitions » COGS-to-Revenue

Comparable Companies

Traded in Other Exchanges

N/A

Address

420 Lexington Avenue, Suite 2012, New York, NY, USA, 10170

Website

http://www.synergypharma.com

Synergy Pharmaceuticals Inc functions in the healthcare sector based in the United States. It focusses on developing therapies to combat gastrointestinal diseases. The company's basic ingredient is the uroguanylin analog, which it employs in its products candidates such as plecanatide and dolcanatide. Plecanatide is a once-daily tablet, which addresses chronic idiopathic constipation and the irritable bowel syndrome. Dolcanatide is meant to cure inflammatory bowel disease by aiding the process of digestive breakdown.

Synergy Pharmaceuticals (FRA:S90) Headlines

No Headlines